Healthcare Exits

How do exits differ within healthcare, specifically within life sciences as the modeling seems to be much more creative and not applicable to traditional buyout.


It seems like VC is ultra competitive and requires advanced degrees. Healthcare services just seems pretty boring.

 

VC is very hard but investment bankers do make it over at junior levels occasionally. Just don't expect it to be the norm. You odds are also higher at a traditional investment based VC firm rather than one of the ones that is basically an incubator now like Flagship. 

Dayman?
 

what firms do headhunters respect the most for VC? does the BB or EB tag matter?

 

I honestly have no idea. I don't really know how much headhunters do for healthcare VC, but of the few people I have seen make the jump from IB to HC VC, they have been from a range of firms including BB, EB, and a healthcare boutique. I am sure BB and EB get generally favored over MM and boutiques, as per usual. I would guess PE experience is valued a lot as well.

Dayman?
 
Most Helpful

Exits from healthcare are pretty broad. VC is possible, although not the norm. You work with a ton of early stage MedTech, biotech and HCIT companies so it’s easy enough to spin a story. GE is pretty common too. Traditional MF/UMM PE is the most common. Almost every PE fund has a healthcare focus and the skillset learned in most the verticals (HCIT, HC Services, MedTech) are very broadly applicable to other industries. Finally, you can exit to HFs—a lot value HC experience. Outside of the buyside, going to corp dev is pretty easy. 

Modeling a biotech company is fairly complex, but it makes modeling any other company a piece of cake. 
 

You can also exit to funds with a specific life sciences focus (Bain cap and blackstone) or maybe a place like Royalty Pharma. However, this isn’t very common. The funds listed are the only ones I really know of that take people post-IB. The majority of life sciences focused investment funds require advanced degrees. 

 

Accusamus dolorum ab velit praesentium cum recusandae officiis enim. Quisquam perferendis et incidunt.

Occaecati reprehenderit qui qui sed eaque dicta sunt. Rem et beatae vitae aut voluptatum. Rerum impedit porro vel excepturi vitae.

Non quibusdam autem non. Doloremque ad placeat iste. Provident possimus a fugit consequatur iusto. Hic similique ipsa sit exercitationem accusantium ut.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
numi's picture
numi
98.8
10
Kenny_Powers_CFA's picture
Kenny_Powers_CFA
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”